Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 86 | 15 | 16 | 13 | 33 |
| Gross Profit | 86 | 15 | 16 | 13 | 33 |
| Operating Expenses | 13,645 | 12,257 | 9,033 | 8,882 | 23,594 |
| Operating Income | -13,559 | -12,242 | -9,017 | -8,870 | -23,562 |
| Other Income | 952 | 677 | 414 | 306 | 295 |
| Pre-tax Income | -12,608 | -11,565 | -8,603 | -8,564 | -23,267 |
| Net Income Continuous | -12,608 | -11,565 | -8,603 | -8,564 | -23,267 |
| Net Income | $-12,608 | $-11,565 | $-8,603 | $-8,564 | $-23,267 |
| EPS Basic Total Ops | -0.17 | -0.17 | -0.16 | -0.15 | -0.55 |
| EPS Basic Continuous Ops | -0.18 | -0.17 | -0.16 | -0.16 | -0.55 |
| EPS Diluted Total Ops | -0.17 | -0.17 | -0.16 | -0.15 | -0.55 |
| EPS Diluted Continuous Ops | -0.18 | -0.17 | -0.16 | -0.16 | -0.55 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.16 | -0.18 | -0.30 |
| EBITDA(a) | $-14,049 | $-12,447 | $-9,006 | $-8,811 | $-23,375 |